Adnexal Mass Segmentation with Ultrasound Data Synthesis
Not on the map. Why?
Abstract (arXiv)
Ovarian cancer is the most lethal gynaecological malignancy. The disease is most commonly asymptomatic at its early stages and its diagnosis relies on expert evaluation of transvaginal ultrasound images. Ultrasound is the first-line imaging modality for characterising adnexal masses, it requires significant expertise and its analysis is subjective and labour-intensive, therefore open to error. Hence, automating processes to facilitate and standardise the evaluation of scans is desired in clinical practice. Using supervised learning, we have demonstrated that segmentation of adnexal masses is possible, however, prevalence and label imbalance restricts the performance on under-represented classes. To mitigate this we apply a novel pathology-specific data synthesiser. We create synthetic medical images with their corresponding ground truth segmentations by using Poisson image editing to integrate less common masses into other samples. Our approach achieves the best performance across all classes, including an improvement of up to 8% when compared with nnU-Net baseline approaches.
Key facts. Cited by 2 papers in the map (data through 7 Oct 2026). Builds on 7 of its 27 references that are in the map. First posted on arXiv 25 Sep 2022.
Builds on
7 of 27 references.
References · 7
- 2018Medical Image Synthesis for Data Augmentation and Anonymization using Generative Adversarial Networkscited by 146
- 2020Detecting Outliers with Foreign Patch Interpolationcited by 44
- 2020Self-Supervised Ultrasound to MRI Fetal Brain Image Synthesiscited by 18
- 2020Mutual Information-based Disentangled Neural Networks for Classifying Unseen Categories in Different Domains: Application to Fetal Ultrasound Imagingcited by 15
- 2019Confident Head Circumference Measurement from Ultrasound with Real-time Feedback for Sonographerscited by 10
- 2018A Novel Domain Adaptation Framework for Medical Image Segmentationcited by 9
- 2020Learning normal appearance for fetal anomaly screening: Application to the unsupervised detection of Hypoplastic Left Heart Syndromecited by 2
Built on by
Citing papers per year: 2023: 1; 2024: 0; 2025: 0; 2026: 1.
2 papers.